Meisner Lara Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$3.52M

Insider Activity of Meisner Lara

According to the SEC Form 4 filings, Meisner Lara, being in a position of

  1. Chief Legal Officer at Bicara Therapeutics Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 79146 shares for $1.02M,
    over all time since 2025-03-14, has bought 0 shares, and sold 79146 shares for $1.02M.

The largest sale of all time was on 2025-03-14 and amounted to 79146 shares of Bicara Therapeutics Inc. Common Stock for $1.02M.

Biography of Meisner Lara

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,021,2111100

Comparison of Insiders on Amount of Buys and Sells

2025-03-14SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Legal Officer
79,146
0.1511%
$12.90$1.02M+5.19%
2023-06-16SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
27
<0.0001%
$28.35$765-34.59%
2023-06-15SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
2,269
0.0054%
$28.02$63,577-36.35%
2023-06-06SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
5,126
0.0121%
$25.02$128,253-28.07%
2023-06-05SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
499
0.0012%
$25.03$12,490-27.62%
2023-06-02SaleViridian Therapeutics, Inc.
VRDN
Chief Legal Officer
1,875
0.0044%
$24.21$45,394-25.76%
2023-03-09SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
29,971
0.0733%
$29.07$871,257-33.06%
2023-01-23SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
6,843
0.0169%
$35.66$244,021-37.4%
2022-12-21SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
16,326
0.0503%
$29.19$476,556-19.67%
2022-12-16SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
1,297
0.0041%
$28.44$36,887-14.56%
2022-12-14SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
15,656
0.0491%
$28.12$440,247-14.61%
2022-11-15SaleViridian Therapeutics, Inc.
VRDN
General Counsel and Secretary
8,125
0.0244%
$22.05$179,156+8.41%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.